Financial

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2023 Financial Results

WARSAW, Ind., Jan. 16, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 8, 2024 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.

The live audio webcast can be accessed via Zimmer Biomet’s Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.

Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (888) 204-4368 and using conference ID 5103691. International callers should dial +1 (323) 994-2093 and use conference ID 5103691.

Additionally, Zimmer Biomet will host an in-person product showcase event for investors and analysts at the American Academy of Orthopaedic Surgeons Conference in San Francisco. The event will take place on Tuesday, February 13, 2024 at 5:30 p.m. PT. Please register prior to attending the event via Zimmer Biomet’s Investor Relations website at https://investor.zimmerbiomet.com/news-and-events/events-and-presentations.

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Media
Heather Zoumas-Lubeski
(445) 248-0577
heather.zoumaslubeski@zimmerbiomet.com

Investors
Zach Weiner
(908) 591-6955
zach.weiner@zimmerbiomet.com

SOURCE Zimmer Biomet Holdings, Inc.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button